Centiva Capital, LP Shockwave Medical, Inc. Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $12,808 - $21,817	-67 Reduced 1.88%	3,500 $1.14 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $574,251 - $769,366	3,567 New	3,567 $679,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $5.42 Million - $7.36 Million	24,317 Added 2178.94%	25,433 $7.26 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $195,757 - $243,198	1,116 New	1,116 $241,000
Q3 2021 Nov 15, 2021	SELL	$163.99 - $235.57 $649,236 - $932,621	-3,959 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$131.45 - $201.49 $520,410 - $797,698	3,959 New	3,959 $751,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.